We are thrilled to announce that MITOS has achieved ISO 13485 certification, marking a significant milestone in our commitment to delivering high-quality medical devices for breast cancer detection and diagnosis.
ISO 13485 is an internationally recognized standard that sets out the requirements for a quality management system specific to the medical device industry. This certification demonstrates MITOS's dedication to upholding the highest standards of quality and regulatory compliance in the development, manufacturing, and distribution of our medical devices.
Obtaining ISO 13485 certification is a rigorous process that involves thorough evaluation of our quality management system, including our processes for design, development, production, and customer service. By meeting the stringent requirements of this standard, MITOS has demonstrated our ability to consistently provide safe and effective medical devices that meet customer and regulatory requirements.
This certification not only validates MITOS's commitment to quality but also enhances our credibility in the medical device industry. It assures our customers, partners, and regulatory authorities that our products are manufactured and maintained to the highest standards, ensuring their safety and effectiveness in clinical use.
At MITOS, we are dedicated to advancing the early detection and screening of breast cancer through innovative and reliable medical technologies. Achieving ISO 13485 certification is a testament to our ongoing commitment to quality and regulatory compliance, and we are proud to have reached this important milestone.
As we continue our journey, we remain committed to delivering cutting-edge solutions that make a positive impact on healthcare outcomes. With ISO 13485 certification, MITOS is poised to further strengthen our position as a trusted leader in breast cancer detection and diagnosis, bringing hope and confidence to patients and healthcare providers worldwide.